RXRX

#1693
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.5 9 USD
+4.97%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
3.59
3.59
년간 변동
2.77
7.18
일일 변동
+4.97%
월간 변동
+7.81%
6달 변화
-19.51%
년간 변동율
-17.47%
이전 종가
3.4 2
Open
3.5 9
저가
3.5 9
High
3.5 9
양
134
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 1.9 B
  • Employee 600
  • Founded 2013
  • CEO Najat Khan
  • Website www.recursion.com
  • Headquarter Delaware, United States
  • FIGI BBG00PQ4XJ45
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-2.84
주가매출액비율
24.5

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

뉴스